Biofrontera Inc. (BFRI)
Nasdaq: BFRI · Pharmaceutical Preparations · Woburn, MA · filing with the SEC since 2021
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 19, 2026 | Mar 20, 2025 | Mar 15, 2024 | Mar 13, 2023 | Apr 11, 2022 | · |
| Revenue | 41,705 | 37,321 | 34,071 | 28,674 | 24,100 | 18,849 |
| For lenders | ||||||
| Interest and dividend income | · | · | · | 165 | · | · |
| Interest and investment income | · | 71 | 132 | 10 | 16 | 28 |
| Net interest income | · | · | -468 | -195 | -344 | -2,869 |
| Research and development | 3,719 | 2,089 | 77 | · | · | · |
| Selling, general and administrative | 37,751 | 33,793 | 38,975 | 35,137 | 36,512 | 17,706 |
| General and administrative | 22,866 | 16,279 | 18,489 | · | · | · |
| Total operating expenses | 53,053 | 54,531 | 56,748 | 47,255 | 49,301 | 28,455 |
| Total costs and expenses | 53,053 | 54,531 | 56,748 | · | · | · |
| Operating income | -11,348 | -17,210 | -22,677 | -18,581 | -25,201 | -9,606 |
| Interest expense | · | · | 220 | 12r | 344 | 2,869 |
| Interest income (expense), net | -452 | -2,035 | -468 | · | · | · |
| Share of profit of equity-method investments | 2 | -14 | -7,421 | 1,747 | · | · |
| Other income (expense), net | 388 | 158 | -75 | 33 | 689 | 1,552 |
| Total non-operating income (expense) | 837 | -527 | 2,560 | 17,973 | -12,456 | -1,317 |
| Income before income taxes | -10,511 | -17,737 | -20,117 | -608 | -37,657 | -10,923 |
| Income tax expense | 25 | 22 | 14 | 32 | 56 | 64 |
| Net income | -10,536 | -17,759 | -20,131 | -640 | -37,713 | -10,987 |
| Net income to common shareholders | · | · | · | · | -37,713 | -10,987 |
| Earnings per share, basic | -1.04 | -3.22 | -13.02 | -0.61r | -85.60b | · |
| Earnings per share, diluted | -1.04 | -3.22 | -13.02 | -0.61 | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -85.60b | -9,589.60b |
| Weighted average shares, basic | 10,171,921 | 5,516,334 | 1,546,297 | 1,056,988r | 440,412b | · |
| Weighted average shares, diluted | 10,171,921 | 5,516,334 | 1,546,297 | 1,056,988 | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 440,411,650b | 1,145,750b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-20 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxInterest and dividend income what its loans and securities earned
us-gaap:InterestIncomeOperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterest
us-gaap:InterestIncomeOtherNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetShare of profit of equity-method investments its share of companies it partly owns
us-gaap:IncomeLossFromEquityMethodInvestmentsOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted